Catalyst Biosciences Forecast and Stock Analysis
Technical CBIO stock analysis for February 15, 2019.
| Shorts | n/a |
| Cash | n/a |
| Loans | n/a |
| Beta | 2.22 |
| ROA | -29.82 |
Catalyst Biosciences gained 6.95% in the last trading day, rising from $8.35 to $8.93 The price has risen in 6 of the last 10 days and is up by 6.69% over the past 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 71 659 more shares were traded than the day before. In total, 264 055 shares bought and sold for approximately $2.36 million.
Close price at the end of the last trading day (Friday, 15th Feb 2019) of the CBIO stock was $8.93. This is 6.95% more than the trading day before Thursday, 14th Feb 2019.
During day the stock fluctuated 8.65% from a day low at $8.32 to a day high of $9.04.
30 day high of the CBIO stock price was $9.29 and low was $7.45.
90 day high was $11.29 and low was $6.20.
52 week high for the Catalyst Biosciences - $33.73 and low - $6.20.
Trend
Catalyst Biosciences has broken the very wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction there will be support on the roof on the current trend broken, which is $8.75, a level that may pose a second chance to hit a runner. According to fan-theory $12.46 will be the next possible trendtop level and thereby pose a resistance level which may not be broken on the first attempt.
Signals
Only positive signals in the chart today. Catalyst Biosciences holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $8.48 and $8.40. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday February 14, 2019, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal.
Access today's Top 5 Golden Star Companies
Relative Strength Index (RSI)
RSI14 is 62 and the stock is currently not being overbought or oversold
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at $8.29 and $7.10.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Catalyst Biosciences finds support just below today's level at $8.29. If this is broken, then the next support from accumulated volume will be at $7.10 and $6.87.
Risk
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.72 between high and low, or 8.65%. For the last week, the stock has had a daily average volatility of 7.20%.
Our recommended stoploss: $8.55 (-4.30%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 1 days ago.)
Overall risk:
Very Low Low Medium High Very High
Evaluation: Buy Candidate
Several short-term signals are positive and the break-up from the falling trend indicates a possible shift for a trend. We believe that the prices around the breaking point will indicate particularly good levels, but we also believe that the current level will hold a possible good buy level for the short-term period. We have upgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Buy Candidate.
